Venue: Leuven, Belgium
The aim of our second international congress is to communicate what the IOTA study has taught us from the study of over 10,000 adnexal masses. Highlights will include preliminary data on IOTA 5 (the classification of masses managed conservatively) and the congress will be the first time the UKCTOCS ovarian cancer screening data will be presented after its publication in early April.
As the core business of IOTA is ultrasonography, there will be an emphasis on the important features of different types of mass as well as the ultrasound variables used in IOTA models and rules. At the end of the meeting we would expect attendees to be fully conversant with these. There will be an opportunity to test your knowledge at the end of the meeting and receive a certificate if you pass the “IOTA test”.
More information on www.iotagroup.org